Photophysical and electrochemical properties of π-extended molecular 2,1,3-benzothiadiazoles

Add time:07/27/2019    Source:sciencedirect.com

The reaction of 4,7-dibromo-2,1,3-benzothiadiazole with arylboronic acids (phenyl, 1-naphthyl, 4-methoxyphenyl, 4-chlorophenyl and 4-trifluoromethylphenyl) in the presence of catalytic amounts of a NCP-pincer palladacycle affords photoluminescent π-extended 4,7-diaryl-2,1,3-benzothiadiazoles 4a–e in high yields. These 4,7-diaryl-2,1,3-benzothiadiazoles exhibit high fluorescent quantum yields, high electron affinities and adequate band gap values for testing as OLEDs. The 4,7-bis-naphthyl-2,1,3-benzothiadiazole 4b presents two different lifetimes (bi-exponential decay) due to the presence of two atropisomers. The Sonogashira coupling reaction of 4,7-diethynyl-2,1,3-benzothiadiazole 6 with the corresponding halo-aryl compounds (iodobenzene, 1-bromonaphthalene, 4-iodoanisole, 4-bromo-N,N-dimethylaniline and 2-bromopyridine) afforded the photoluminescent π-extended 4,7-bis-alkynylaryl-2,1,3-benzothiadiazoles 7a–e, also in high yields. These 4,7-diethynyl-2,1,3-benzothiadiazoles also present high fluorescent quantum yields, high electron affinities and adequate band gap values for testing as OLEDs. The 4,7-disubstituted-2,1,3-benzothiadiazoles 4a–e and 7a–e exhibit different electrochemical behavior. The presence of two ethynyl spacers in 2,1,3-benzothiadiazoles 7a–e shifts the reduction potentials to less cathodic values and also results in two well-defined and distinct reduction processes.

We also recommend Trading Suppliers and Manufacturers of 4,7-DIBROMO-2,1,3-BENZOTHIADIAZOLE (cas 15155-41-6). Pls Click Website Link as below: cas 15155-41-6 suppliers

Prev:Effect of asymmetrical peripheral substitution of sulfonic acid group on the geometric and electronic structures and vibrations of copper phthalocyanine studied by computational and experimental techniques
Next:Synthesis and tautomerism of 9-azabicyclo[4.2.l]nonan-1-ols (Norhomotropan-1-ols), N-alkyl and 7,8-dehydro- derivatives, and oxabicyclic analogues)